We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Heller, GL, DeJong, RN.Treatment of the Guillain-Barré syndrome.Use of corticotropin and glucocorticoids. Arch Neurol1963;8:179–193.CrossRefGoogle Scholar
2
2.Goodall, JAD, Kosmidis, JC, geddes, AM.Effect of corticosteroidson course of Guillain-Barré syndrome (letter). Lancet1974;1:524.CrossRefGoogle Scholar
3
3.Hughes, RC, Van der Meche, FG.Corticosteroids for treatingGuillain-Barré syndrome. Cochrane Database of Systematic Reviews2001;2.Google Scholar
4
4.Dyck, PJB, Norell, JE, Dyck, PJ.Methylprednisolone may improveLumbosacral Radiculoplexus Neuropathy. Can J Neurol Sci2001;28:224–227.Google Scholar
5
5.Dyck, PJB, Norell, JE,Dyck, PJ.Non-diabetic lumbosacral radiculo-plexus neuropathy. Natural history, outcome and comparison with the diabetic variety. Brain2001;124(Pt 6):1197–1207.Google Scholar
6
6.Dyck, PJ, O’Brien, PC, Oviatt, KF, et al.Prednisone improves chronicinflammatory demyelinating polyneuropathy more than no treatment. Ann Neurol1982;11:136–141.Google Scholar